Uncategorized
Detested ex-hedge funder increases price of pill protecting AIDS, cancer patients 5,000% overnight, drawing outcry
A detested ex-hedge funder's company is charging 5,000% more for a pill that protects AIDS and cancer patients — a drastic move that came overnight and angered public health officials. Martin Shkreli’s Turing Pharmaceuticals raised the price of a Daraprim tablet — a 62-year-old drug that fights against the life-threatening…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: NY Daily News